Neogen Corporation (NEOG)Healthcare | Medical Devices | Lansing, United States | NasdaqGS
9.65 USD
+0.03
(0.312%)
⇧
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 6:47 a.m. EDT
The investment case for Neogen is currently broken by a catastrophic multi-year decline. The stock has lost 75% of its value over the last nine years, with four consecutive years of negative annual returns ending in a massive 66% drop last year. This is not a temporary correction; it is a structural implosion where the market has priced out the business entirely. Fundamentals confirm the distress: the company is generating negative earnings, negative operating margins, and negative return on equity, while revenue is shrinking. The balance sheet is fragile with debt significantly outweighing cash reserves. While the price-to-book ratio appears attractive at roughly 1x, this is a classic value trap where the low price reflects the reality of a failing operation rather than a margin of safety. There is no dividend to provide income, and the recent price action shows no signs of stabilization. The heavy put option activity confirms that smart money is hedging against further downside rather than betting on a recovery. Until there is clear evidence of a turnaround in revenue growth and profitability, this remains a severe avoid. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.034328 |
| AutoTheta | 0.035013 |
| AutoETS | 0.051388 |
| MSTL | 0.055319 |
| MSTL_126 | 0.104809 |
Forecast horizon: 60 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 1.63 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.650 |
| Excess Kurtosis | 0.34 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 37.819 |
| Revenue per Share | 4.006 |
| Market Cap | 2,100,544,768 |
| Forward P/E | 32.17 |
| Beta | 1.79 |
| Profit Margins | -69.94% |
| Website | https://www.neogen.com |
As of July 11, 2026, 6:47 a.m. EDT: Speculators are positioning defensively with heavy put volume at the $7.50 strike across multiple expirations, creating a significant floor. Call activity is sparse and concentrated at the money ($10), suggesting limited aggressive upside bets despite the stock trading near its 52-week high relative to recent lows. Implied volatility is elevated on downside protection compared to upside speculation.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.9416499 |
| Address1 | 620 Lesher Place |
| All Time High | 48.85 |
| All Time Low | 0.122253 |
| Ask | 12.28 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Daily Volume10 Day | 1,644,370 |
| Average Daily Volume3 Month | 2,290,619 |
| Average Volume | 2,290,619 |
| Average Volume10Days | 1,644,370 |
| Beta | 1.794 |
| Bid | 7.0 |
| Bid Size | 2 |
| Board Risk | 3 |
| Book Value | 9.659 |
| City | Lansing |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 9.65 |
| Current Ratio | 3.918 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 9.75 |
| Day Low | 9.515 |
| Debt To Equity | 37.819 |
| Display Name | Neogen |
| Earnings Call Timestamp End | 1,775,736,000 |
| Earnings Call Timestamp Start | 1,775,736,000 |
| Earnings Timestamp End | 1,775,737,800 |
| Earnings Timestamp Start | 1,775,737,800 |
| Ebitda | 81,262,000 |
| Ebitda Margins | 0.093339995 |
| Enterprise To Ebitda | 33.666 |
| Enterprise To Revenue | 3.143 |
| Enterprise Value | 2,735,744,768 |
| Eps Current Year | 0.37 |
| Eps Forward | 0.3 |
| Eps Trailing Twelve Months | -2.8 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 9.0924 |
| Fifty Day Average Change | 0.5576 |
| Fifty Day Average Change Percent | 0.06132595 |
| Fifty Two Week Change Percent | 94.16499 |
| Fifty Two Week High | 11.43 |
| Fifty Two Week High Change | -1.7800007 |
| Fifty Two Week High Change Percent | -0.15573059 |
| Fifty Two Week Low | 4.56 |
| Fifty Two Week Low Change | 5.0899997 |
| Fifty Two Week Low Change Percent | 1.116228 |
| Fifty Two Week Range | 4.56 - 11.43 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 619,882,200,000 |
| Float Shares | 216,471,486 |
| Forward Eps | 0.3 |
| Forward P E | 32.166664 |
| Free Cashflow | 19,474,124 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 2,974 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.45209 |
| Gross Profits | 393,576,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00949 |
| Held Percent Institutions | 1.13774 |
| Implied Shares Outstanding | 217,673,041 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ir Website | http://www.neogen.com/Corporate/invest.html |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,748,649,600 |
| Last Split Date | 1,623,024,000 |
| Last Split Factor | 2:1 |
| Long Business Summary | Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals. This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. |
| Long Name | Neogen Corporation |
| Market | us_market |
| Market Cap | 2,100,544,768 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_339683 |
| Most Recent Quarter | 1,772,236,800 |
| Net Income To Common | -608,844,032 |
| Next Fiscal Year End | 1,780,185,600 |
| Non Diluted Market Cap | 2,100,544,845 |
| Number Of Analyst Opinions | 3 |
| Open | 9.59 |
| Operating Cashflow | 69,444,000 |
| Operating Margins | -0.01563 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.66 |
| Phone | 517 372 9200 |
| Pre Market Change | 0.03999996 |
| Pre Market Change Percent | 0.4145074 |
| Pre Market Price | 9.69 |
| Pre Market Time | 1,784,032,178 |
| Previous Close | 9.62 |
| Price Eps Current Year | 26.08108 |
| Price Hint | 2 |
| Price To Book | 0.99906814 |
| Price To Sales Trailing12 Months | 2.4128633 |
| Profit Margins | -0.69936997 |
| Quick Ratio | 1.972 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0299997 |
| Regular Market Change Percent | 0.311848 |
| Regular Market Day High | 9.75 |
| Regular Market Day Low | 9.515 |
| Regular Market Day Range | 9.515 - 9.75 |
| Regular Market Open | 9.59 |
| Regular Market Previous Close | 9.62 |
| Regular Market Price | 9.65 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 1,405,693 |
| Return On Assets | -0.00607 |
| Return On Equity | -0.25566998 |
| Revenue Growth | -0.044 |
| Revenue Per Share | 4.006 |
| Sand P52 Week Change | 0.20365608 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 217,673,041 |
| Shares Percent Shares Out | 0.0482 |
| Shares Short | 10,491,465 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 13,034,627 |
| Short Name | Neogen Corporation |
| Short Percent Of Float | 0.0644 |
| Short Ratio | 4.73 |
| Source Interval | 15 |
| State | MI |
| Symbol | NEOG |
| Target High Price | 13.0 |
| Target Low Price | 11.0 |
| Target Mean Price | 12.0 |
| Target Median Price | 12.0 |
| Total Cash | 159,900,000 |
| Total Cash Per Share | 0.735 |
| Total Debt | 795,100,032 |
| Total Revenue | 870,561,024 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.8 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 8.37735 |
| Two Hundred Day Average Change | 1.2726498 |
| Two Hundred Day Average Change Percent | 0.15191555 |
| Type Disp | Equity |
| Volume | 1,405,693 |
| Website | https://www.neogen.com |
| Zip | 48,912-1595 |